文献速递皮肤肿瘤

同行数据透明化干预对Mohs显微描记手术过度使用的效果评价

Evaluation of a Peer-to-Peer Data Transparency Intervention for Mohs Micrographic Surgery Overuse.
PubMed 文献 · JAMA Dermatol · 2019-01-01

该非随机对照干预研究纳入2016至2018年美国2329名Mohs显微描记手术医生,向干预组所有离群及非离群医生秘密反馈其每例平均阶段数与全国同行基准。

要点

  • 向医生秘密反馈同行基准的每例阶段数可减少Mohs手术过度使用。
  • 干预组离群医生每例阶段数多下降0.14个,具统计学意义。

核心结论

  • 向医生分享其个人实践模式数据并与同行基准比较,可减少离群医生的Mohs显微描记手术过度使用。

研究设计与样本

  • 非随机对照干预研究,纳入2016年1月1日至2018年3月31日实施Mohs手术的2329名美国医生,通过Medicare Part B理赔100%捕获识别。
  • 干预组为美国Mohs外科学会附属医生(n=1045),对照组为非附属医生(n=1284)。
  • 向干预组所有离群医生(每例平均阶段数高于均值2个标准差)及非离群医生发送个体化绩效报告。

主要发现

  • 干预组离群医生53名(5.1%),对照组离群医生87名(6.8%)。
  • 干预组离群医生每例平均阶段数平均下降12.6%,对照组离群医生下降9.0%。

关键数值与推荐

  • 离群医生定义为每例平均阶段数高于均值2个标准差。
  • 主要结局为医生层面每例平均阶段数在通知前(2016年1月至2017年1月)与通知后(2017年3月至2018年3月)的变化。
  • 每例平均阶段数指标未进行风险校正。

临床怎么用

  • 可考虑向Mohs手术医生秘密反馈其每例阶段数与全国同行基准,以降低离群医生的过度使用。
  • 该干预成本较低,可能带来显著的费用节省。

局限性

  • 研究为非随机设计,干预组与对照组基于学会附属关系划分,可能存在混杂。
  • 每例平均阶段数指标未进行风险校正。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Mohs micrographic surgery (MMS) is a skin cancer treatment that uses staged excisions based on margin status. Wide surgeon-level variation exists in the mean number of staged resections used to treat a tumor, resulting in a cost disparity and question of appropriateness. OBJECTIVE: To evaluate the effectiveness of a behavioral intervention aimed at reducing extreme overuse in MMS, as defined by the specialty society, by confidentially sharing stages-per-case performance data with individual surgeons benchmarked to their peers nationally. DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized controlled intervention study included 2329 US surgeons who performed MMS procedures from January 1, 2016, to March 31, 2018. Physicians were identified using a 100% capture of Medicare Part B claims. The intervention group included physicians affiliated with the American College of Mohs Surgery, and the control group included physicians not affiliated with the American College of Mohs Surgery. INTERVENTIONS: Individualized performance reports were delivered to all outlier surgeons, defined by the specialty society as those with mean stages per case 2 SDs above the mean, and inlier surgeons in the intervention group. MAIN OUTCOMES AND MEASURES: The primary outcome was surgeon-level change in mean stages per case between the prenotification (January 2016 to January 2017) and postnotification (March 2017 to March 2018) periods. A multivariable linear regression model was used to evaluate the association of notification with this surgeon-level outcome. The surgeon-level metric of mean stages per case was not risk adjusted. The mean Medicare cost savings associated with changes in practice patterns were calculated. RESULTS: Of the 2329 included surgeons, 1643 (70.5%) were male and 2120 (91.0%) practiced in metropolitan areas. In the intervention group (n = 1045), 53 surgeons (5.1%) were outliers; in the control group (n = 1284), 87 surgeons (6.8%) were outliers. Among the outliers in the intervention group, 44 (83%) demonstrated a reduction in mean stages per case compared with 60 outliers in the control group (69%; difference, 14%; 95% CI of difference, -1 to 27; P = .07). There was a mean stages-per-case reduction of 12.6% among outliers in the intervention group compared with 9.0% among outliers in the control group, and outliers in the intervention group had an adjusted postintervention differential decrease of 0.14 stages per case (95% CI, -0.19 to -0.09; P = .002). The total administrative cost of the intervention program was $150 000, and the estimated reduction in Medicare spending was $11.1 million. CONCLUSIONS AND RELEVANCE: Sharing personalized practice pattern data with physicians benchmarked to their peers can reduce overuse of MMS among outlier physicians.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Albertini JG, Wang P, Fahim C, et al. Evaluation of a Peer-to-Peer Data Transparency Intervention for Mohs Micrographic Surgery Overuse. JAMA Dermatol. 2019. PMID: 31055597. doi:10.1001/jamadermatol.2019.1259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。